| Role |
Name |
Disclosure |
Details |
| Author | Ferenc Kuhn, MD, PhD, Associate Professor of Clinical Ophthalmology, University of Alabama at Birmingham; Consulting Staff, American Society of Ocular Trauma, Helen Keller Foundation for Research and Education | Nothing to disclose | Details | | Coauthor | David T Wong, MD, FRCS(C), Associate Professor of Ophthalmology, Director of Fellowship Programs, Department of Ophthalmology, St Michael's Hospital, Faculty of Medicine, University of Toronto, Canada | Occulogix Novartis Alcon Labtician | Details | | Coauthor | Louis Giavedoni, MD, FRCSE, Co-Chief, Assistant Professor, Department of Ophthalmology, St Michael's Hospital, University of Toronto, Canada | Nothing to disclose | Details | | Medical Editor | Andrew W Lawton, MD, Medical Director of Neuro-Ophthalmology Service, Section of Ophthalmology, Baptist Eye Center, Baptist Health Medical Center | Nothing to disclose | Details | | Pharmacy Editor | Simon K Law, MD, PharmD, Assistant Professor of Ophthalmology, Jules Stein Eye Institute; Chief of Section of Ophthalmology Surgical Services, Department of Veterans Affairs Healthcare Center, West Los Angeles | Nothing to disclose | Details | | Managing Editor | Steve Charles, MD, Director of Charles Retina Institute; Clinical Professor, Department of Ophthalmology, University of Tennessee College of Medicine | Alcon Laboratories | Details | | CME Editor | Lance L Brown, OD, MD, Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri | Nothing to disclose | Details | | Chief Editor | Hampton Roy Sr, MD, Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Louis Giavedoni, Coauthor |
The contributor discloses no conflict of interest. |
|